CompositionPeminib 13.5 Tablet: Each tablet contains Pemigatinib INN 13.5 mg.PharmacologyPemigatinib is a small molecule kinase inhibitor that targets FGFR1, 2 and 3 with IC50 values of lessthan 2 nM. Pemigatinib also inhibited FGFR4 in vitro at a concentration approximately 100…
Indications Ventoxen in combination with Rituximab is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy. Ventoxen monotherapy is indicated for the treatment of CLL: * রেজিস্টার্ড চিকিৎসকের পরামর্শ…
Indications Renal Cell Carcinoma: Caboxen is indicated for the treatment of patients with advanced renal cell carcinoma (RCC). Hepatocellular Carcinoma: Caboxen is indicated for the treatment of patients with hepatocellular carcinoma (HCC) who have been previously treated with Sorafenib. *…
(Osimertinib (Tagrix) is the 1st and only drug of its kind approved by USFDA for the treatment of epidermal growth factor receptor (EGFR) positive Non- Small Cell Lung Cancer (NSCLC) patient with T790M mutation. Therapeutic indications TAGRIX is indicated for…
Indications Breast Cancer: Olanib is indicated as monotherapy for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm), human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer who have previously been treated with chemotherapy in…
Indications Rematib is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with moderate to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন‘ Pharmacology…
